Products
Community
Markets
Brokers
More

Ideas
CRBU

CRBU

$CRBU- great long term play I've been watching NASDAQ:CRBU for a couple of years waiting for it to start looking good for a trade, and it finally looks like the time is right. I ended up buying today. A sustained breakout above the $2.70 level, and flipping that level as support should bring a larger move. I've marked off key resistance levels on the path up to the highs.

Long

CRBU Caribou Biosciences Options Ahead of Earnings Analyzing the options chain and the chart patterns of CRBU Caribou Biosciences prior to the earnings report this week, I would consider purchasing the 5usd strike price in the money Calls with an expiration date of 2023-9-15, for a premium of approximately $0.85. If these options prove to be profitable prior to the earnings release, I would sell at least half of them. Looking forward to read your opinion about it.

Long

Updated

CRBU Don't you have enough capital? No problem. There are always new opportunities at stock market. This a long bullish trade. The areas close to the circle are pending orders that need to be filled. Charts don't lie

Long

by Ricardoptions

CRBU | Informative NASDAQ:CRBU If the price of CRBU breaks above the bullish line of $7.49, it may indicate a bullish signal, suggesting potential upward price movement. In this scenario, the target price could be set at $8.65. Conversely, if the price of CRBU breaks below the bearish line of $6.86, it may suggest a bearish signal, implying potential downward price movement. In this case, the target price could be set at $5.95.

CRBU looking like a good trade We have bottomed out here potentially and appear to be under accumulation on the higher time frames. The Bollinger Bands are compressing quite nicely and we could have a nice little squeeze up to the the 200 ma or higher in my opinion. Not financial advice, DYOR. “Caribou is a leader in the CRISPR field, successfully leveraging its proprietary genome-editing technology to develop allogeneic cell therapies that are potentially transformative for patients.”

Long

by ChartProphet

Select market data provided by ICE Data Services. Select reference data provided by FactSet. Copyright © 2025 FactSet Research Systems Inc.Copyright © 2025, American Bankers Association. CUSIP Database provided by FactSet Research Systems Inc. All rights reserved. SEC fillings and other documents provided by Quartr.© 2025 TradingView, Inc.

More than a product

Supercharts

Screeners

Stocks
ETFs
Bonds
Crypto coins
CEX pairs
DEX pairs
Pine

Heatmaps

Stocks
ETFs
Crypto

Calendars

Economic
Earnings
Dividends

More products

Yield Curves
Options
News Flow
Pine Script®

Apps

Mobile
Desktop

Community

Social network
Wall of Love
Refer a friend
House Rules
Moderators

Ideas

Trading
Education
Editors' picks

Pine Script

Indicators & strategies
Wizards
Freelancers

Tools & subscriptions

Features
Pricing
Market data

Trading

Overview
Brokers

Special offers

CME Group futures
Eurex futures
US stocks bundle

About company

Who we are
Space mission
Blog
Careers
Media kit

Merch

TradingView store
Tarot cards for traders
The C63 TradeTime

Policies & security

Terms of Use
Disclaimer
Privacy Policy
Cookies Policy
Accessibility Statement
Security tips
Bug Bounty program
Status page

Business solutions

Widgets
Charting libraries
Lightweight Charts™
Advanced Charts
Trading Platform

Growth opportunities

Advertising
Brokerage integration
Partner program
Education program

Community

Social network
Wall of Love
Refer a friend
House Rules
Moderators

Ideas

Trading
Education
Editors' picks

Pine Script

Indicators & strategies
Wizards
Freelancers

Business solutions

Widgets
Charting libraries
Lightweight Charts™
Advanced Charts
Trading Platform

Growth opportunities

Advertising
Brokerage integration
Partner program
Education program